EODData

MEMBERSHIP REGISTER LOG IN

FRA, PH4: PATTIES FOODS - Frankfurt Stock Exchang

23 Dec 2025
LAST:

0.6250

CHANGE:
 0.00		OPEN:
0.6150		HIGH:
0.6250		ASK:
0.0000		VOLUME:
256
CHG(%):
0.00		PREV:
0.6250		LOW:
0.6150		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Dec 250.61500.62500.61500.6250256
22 Dec 250.62500.62500.62500.6250256
19 Dec 250.64500.64500.64500.6450256
18 Dec 250.62000.62000.62000.6200256
17 Dec 250.60500.60500.60000.6000256
16 Dec 250.60500.60500.59500.5950256
15 Dec 250.63000.66000.63000.63004.2K
12 Dec 250.65500.65500.65000.65001.2K
10 Dec 250.64500.64500.64000.64001.2K
09 Dec 250.61000.61000.60500.60501.2K

PROFILE

Name:PATTIES FOODS - Frankfurt Stock Exchang
About:CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, and relapsed or refractory natural killer/T cell lymphoma; GAVRETO (pralsetinib), a RET inhibitor to treat patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers, as well as NSCLC and multiple tumors; and AYVAKIT (avapritinib), a KIT/PDGFRA inhibitor for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation, and systematic mastocytosis. Its product pipeline includes Nofazinlimab (CS 1003), a PD-1 antibody to treat patients with hepatocellular carcinoma. The company's products also comprise CS1002, CS2009, CS2011, CS5007, CS5005, CS5008, CS5005-R, CS5006, and CS5009 for the treatment of solid tumors; CS5001 to treat solid tumors and hematologic malignancies; and CS2013 and CS2015 for the treatment of autoimmune diseases. CStone Pharmaceuticals was incorporated in 2015 and is headquartered in Suzhou, China.
Sector:Healthcare
Industry:Biotechnology
Address:C1 Building, Suzhou, China, 215123
Website:https://www.cstonepharma.com
ISIN:KYG2588M1006
LEI:300300095A57F80T2461

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-9.50 
Price to Sales:4.99 
Price to Book:2.94 
Profit Margin:-1.86 
Operating Margin:-5.60 
Return on Assets:-0.17 
Return on Equity:-0.96 
Revenue:24.67M 
Shares:1.457B 
Market Cap:910.68M 

TECHNICAL INDICATORS

MA5:0.620.3%
MA10:0.620.2%
MA20:0.620.1%
MA50:0.676.4%
MA100:0.8129.2%
MA200:0.612.6%
STO9:46.15
STO14:46.15
RSI14:52.38
WPR14:-45.45
MTM14:0.02
ROC14:0.03 
ATR:0.02 
Week High:0.653.2%
Week Low:0.605.0%
Month High:0.699.6%
Month Low:0.602.6%
Year High:1.35116.0%
Year Low:0.23169.4%
Volatility:23.05 

RECENT DIVIDENDS

Date Amount
21 Mar 2016$0.04
15 Sep 2015$0.07
15 Sep 2014$0.06
13 Mar 2014$0.03
11 Sep 2013$0.04
13 Mar 2013$0.03
11 Sep 2012$0.04
13 Mar 2012$0.04
08 Sep 2011$0.04
11 Mar 2011$0.04